| No. | Tajuk | Tahun | |
|---|---|---|---|
| 1 | Breath Test For Tuberculosis | 2024 |  |
| 2 | Tertiary Care Virtual Online Consultation Between Doctor And Patient | 2023 | |
| 3 | Nasojejunal Tube in Upper Gastrointestinal Conditions | 2023 | |
| 4 | Ultra Portable Digital X-Ray System For Tuberculosis Screening | 2023 | |
| 5 | Bio-Electrical Impedance Analysis For The Assessment Of Sarcopenia In Elderly | 2023 | |
| 6 | Human Skin Allograft | 2023 | |
| 7 | Acupunture As An Adjunct Treatment For Subfertility | 2023 | |
| 8 | Negative Pressure Wound Therapy | 2023 | |
| 9 | Far Infrated Therapy For Arteriovenous Fistulas And Wound Healing | 2023 | |
| 10 | Extracorporeal Shockwave Therapy For The Treatment Of Erectile Dysfunction | 2023 | |
| 11 | Light Emmiting Diode Fluorescent Microscope Indetecting Mycobacterium Leprae | 2022 | |
| 12 | Mobile C-Arm Fluoroscopy for Cardiothoracic Surgery | 2022 | |
| 13 | Platelet Rich Plasma (PRP), Platelet-Rich Fibrin (PRF) and Concentrated Growth Factor (CGF) for Periodontal Therapy | 2022 | |
| 14 | Proton Beam Therapy For The Treatment Of Cancer – Update | 2022 | |
| 15 | Custodiol HTK as a replacement of blood cardioplegia in cardiac surgery | 2022 | |
| 16 | Therapeutic Drug Monitoring (TDM) for Anti-Tuberculosis | 2022 | |
| 17 | Robotic Arm-Assisted Surgery In Total Hip Arthroplasty | 2022 | |
| 18 | Driving Simulator in Healthcare | 2022 | |
| 19 | First Line Targeted Therapy for Advanced Hepatocellular Carcinoma (aHCC) | 2022 | |
| 20 | Artificial Intelligence Based Chest X-Ray For Lung Cancer Screening | 2022 | |
| 21 | Mesenchymal Stem Cells For Retinitis Pigmentosa And Other Degenerative Retina Disease | 2022 | |
| 22 | Intra-articular Injection of Hyaluronic Acid combined with Sorbitol / Mannitol for Osteoarthritis | 2022 | |
| 23 | Versajet Hydrosurgery System For Wound Debridement : An Update (Executive Summary Dan Full Report) | 2022 | |
| 24 | Viscoelastic haemostatic assay for non-cardiac surgery | 2022 | |
| 25 | Transcutaneous Oxygen Pressure Monitoring (TcPO2) | 2022 | |